SAN DIEGO, Oct. 02, 2017 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is coming up on October 3, 2017 in the lawsuit that was filed for certain investors in Envision Healthcare Corp EVHC shares over alleged Securities Laws Violations by Envision Healthcare Corp.
Investors who purchased shares of Envision Healthcare Corp EVHC have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that EmCare routinely arranged for patients who sought treatment at in-network facilities to be treated by out-of-network physicians, that EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians, that the Company's statements attributing EmCare's Class Period growth to other factors were therefore false and/or misleading, that Envision's EmCare revenues were likely to be unsustainable after the foregoing conduct came to light, and that as a result of the foregoing, Envision's public statements were materially false and misleading at all relevant times.
Those who purchased Envision Healthcare Corp EVHC shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.